FIbrocell Science Announces Exclusive Technology License Agreements...

... of Molecular and Medical Pharmacology at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research. Fibrocell Science, Inc. (NYSE MKT:FCSC) is an autologous cell therapy company primarily focused on developing first-in-class ...

http://ift.tt/1nMylhz